Search by PDB author

Crystal structure of cytochrome P450mel 107F1 in complex with heme and imidazole
Descriptor:	Cytochrome P-450, IMIDAZOLE, PROTOPORPHYRIN IX CONTAINING FE
Authors:	Hou, X.D, Rao, Y.J, Icyishaka, P, Li, C.X, Lou, J.L.
Deposit date:	2019-09-25
Release date:	2020-09-23
Last modified:	2023-11-22
Method:	X-RAY DIFFRACTION (1.601 Å)
Cite:	Crystallization and X-ray analysis of cytochrome P450mel 107F1 with biaryl coupling reactivity To Be Published

Crystal structure of cytochrome P450mel 107F1 with biaryl coupling reactivity
Descriptor:	Cytochrome P-450, PROTOPORPHYRIN IX CONTAINING FE
Authors:	Hou, X.D, Rao, Y.J, Icyishaka, P, Li, C.X, Lou, J.L.
Deposit date:	2019-09-25
Release date:	2020-09-23
Last modified:	2023-11-22
Method:	X-RAY DIFFRACTION (3.5 Å)
Cite:	Crystallization and X-ray analysis of cytochrome P450mel 107F1 with biaryl coupling reactivity To Be Published

Crystal structure of trimethoprim-resistant type II dihydrofolate reductase in complex with a bisbenzimidazole inhibitor
Descriptor:	(4R)-2-METHYLPENTANE-2,4-DIOL, 2-(4-{3-[4-(6-carboxy-1H-benzimidazol-2-yl)phenoxy]-2-hydroxypropoxy}phenyl)-1H-benzimidazole-5-carboxylic acid, Dihydrofolate reductase type 2, ...
Authors:	Yachnin, B.J, Berghuis, A.M.
Deposit date:	2019-02-10
Release date:	2019-05-29
Last modified:	2023-10-11
Method:	X-RAY DIFFRACTION (1.4 Å)
Cite:	Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues. Acs Omega, 4, 2019

Crystal structure of trimethoprim-resistant type II dihydrofolate reductase in complex with a bisbenzimidazole inhibitor
Descriptor:	(4R)-2-METHYLPENTANE-2,4-DIOL, 2-[4-[(2~{R})-4-[4-(6-carboxy-1~{H}-benzimidazol-2-yl)phenoxy]-2-oxidanyl-butoxy]phenyl]-1~{H}-benzimidazole-5-carboxylic acid, Dihydrofolate reductase type 2, ...
Authors:	Yachnin, B.J, Berghuis, A.M.
Deposit date:	2019-02-10
Release date:	2019-05-29
Last modified:	2023-10-11
Method:	X-RAY DIFFRACTION (1.75 Å)
Cite:	Structure-Based Design of Dimeric Bisbenzimidazole Inhibitors to an Emergent Trimethoprim-Resistant Type II Dihydrofolate Reductase Guides the Design of Monomeric Analogues. Acs Omega, 4, 2019